Sestrins: A New Kid for Stroke Treatment?

  • Shi X
  • Xu L
  • Malagult J
  • et al.
4Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: The sestrin family includes several conserved stress-induced proteins that contribute to the maintenance of homeostasis, DNA stability and cell viability in response to various types of injuries. Objective: It is well established that the protective functions of AMP-dependent protein kinase (AMPK) and/or mammalian target of rapamycin (mTOR) are regulated by sestrins. Additionally, it has been revealed that sestrins are able to protect cells from oxidative stress by scavenging reactive oxygen species (ROS). Method: The essential involvement of sestrins in mTORC1 inhibition and ROS scavenging signaling pathways, which modulate metabolism homeostasis and regulate autophagy, indicates that sestrins may serve as a potential agent for cell growth, development, metabolism, and neurodegenerative disorders. However, the potential role of sestrins in stroke has not been discussed and summarized. Results & Conclusion: Based on the current understanding of sestrins, it is believed that sestrins are one of the potential endogenous protective molecules/mechanisms following cerebral stroke, which are associated with neuronal protection, neuroinflammation suppression, and blood brain barrier preservation. © 2017 Bentham Science Publishers.

Cite

CITATION STYLE

APA

Shi, X., Xu, L., Malagult, J., Tang, J., Yan, M., & Zhang, J. H. (2016). Sestrins: A New Kid for Stroke Treatment? Current Drug Delivery, 14(6). https://doi.org/10.2174/1567201814666161111125249

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free